Tag
Antidepressants
32 genetic variants with this tag.
| RSID | Gene | Description | Category | ||
|---|---|---|---|---|---|
| rs10403955 | CYP2B6 | Intronic CYP2B6 haplotype-tagging variant associated with altered plasma conc... | Pharmacogenomics | Moderate | |
| rs1058164 | CYP2D6 | Synonymous CYP2D6 variant that promotes exon 3 skipping, reducing functional ... | Pharmacogenomics | Moderate | |
| rs1065852 | CYP2D6 *10 | Decreased function CYP2D6 variant common in Asian populations | Pharmacogenomics | Established | |
| rs1360780 | FKBP5 Intronic C>T | Co-chaperone of the glucocorticoid receptor that regulates cortisol feedback ... | Mood & Behavior | Strong | |
| rs1080985 | CYP2D6 *2A promoter | CYP2D6 promoter variant (-1584C>G) that reduces enzyme expression; the C alle... | Pharmacogenomics | Strong | |
| rs1387923 | NTRK2 NTRK2/TrkB 3'UTR variant | 3' UTR variant in the TrkB receptor gene affecting NTRK2 expression; associat... | Mood & Behavior | Moderate | |
| rs12248560 | CYP2C19 *17 | Increased function CYP2C19 variant - rapid/ultrarapid metabolizer | Pharmacogenomics | Established | |
| rs1800544 | ADRA2A ADRA2A Promoter -1291C>G | Promoter variant that alters alpha-2A adrenergic receptor expression, affecti... | Appetite & Obesity | Moderate | |
| rs12721627 | CYP3A4 *16 | Missense variant reducing CYP3A4 enzyme activity by 50–74% depending on subst... | Pharmacogenomics | Moderate | |
| rs16947 | CYP2D6 *2 | Common CYP2D6 variant defining the *2 allele; previously considered normal-fu... | Pharmacogenomics | Strong | |
| rs2371365 | PCLO PCLO Presynaptic Scaffold | Intronic variant in the presynaptic scaffold gene PCLO linked to altered mono... | Mood & Behavior | Moderate | |
| rs2522833 | PCLO Ser4814Ala | Missense variant in the C2A calcium-binding domain of presynaptic scaffolding... | Mood & Behavior | Moderate | |
| rs25531 | SLC6A4 A>G | Promoter SNP near 5-HTTLPR that modifies serotonin transporter expression and... | Mood & Behavior | Moderate | |
| rs2069526 | CYP1A2 -739T>G | Intronic CYP1A2 variant near the 5' end; G allele is associated with altered ... | Pharmacogenomics | Emerging | |
| rs6295 | HTR1A C-1019G | Functional promoter variant in the serotonin 1A receptor gene that increases ... | Mood & Behavior | Strong | |
| rs6311 | HTR2A -1438G>A | Regulatory variant in serotonin 2A receptor gene affecting SSRI side effects ... | Mood & Behavior | Moderate | |
| rs28371706 | CYP2D6 *17 | Decreased-function CYP2D6 allele common in African populations, reducing meta... | Pharmacogenomics | Established | |
| rs28371725 | CYP2D6 *41 | Intronic splice variant causing decreased CYP2D6 enzyme activity through aber... | Pharmacogenomics | Established | |
| rs28371733 | CYP2D6 | Rare CYP2D6 stop-gain variant (Glu418Ter) that eliminates enzyme activity, ca... | Pharmacogenomics | Established | |
| rs28695233 | CYP2D6 | Deep intronic CYP2D6 variant in intron 2 that serves as a haplotype tag in sp... | Pharmacogenomics | Emerging | |
| rs35599367 | CYP3A4 *22 | Intronic splice variant causing ~50% reduced CYP3A4 mRNA expression, affectin... | Pharmacogenomics | Established | |
| rs373489637 | CYP2B6 V183G | Near-complete loss-of-function CYP2B6 variant causing severely impaired metab... | Pharmacogenomics | Moderate | |
| rs3745274 | CYP2B6 516G>T | Decreased-function variant affecting metabolism of efavirenz, methadone, bupr... | Pharmacogenomics | Established | |
| rs3758581 | CYP2C19 Ile331Val (CYP2C19*1B) | Common CYP2C19 missense variant defining the *1B allele; the G (Val331) allel... | Pharmacogenomics | Moderate | |
| rs5443 | GNB3 C825T | Synonymous exon-10 variant that triggers alternative splicing of the G-protei... | Hormones & Sleep | Strong | |
| rs3892097 | CYP2D6 *4 | CYP2D6 *4 splice-defect null allele — the most common loss-of-function CYP2D6... | Pharmacogenomics | Established | |
| rs4244285 | CYP2C19 *2 | No-function CYP2C19 variant affecting PPIs, clopidogrel, and some antidepress... | Pharmacogenomics | Established | |
| rs4986893 | CYP2C19 *3 | No-function CYP2C19 stop-gain variant — second most common loss-of-function a... | Pharmacogenomics | Established | |
| rs5030655 | CYP2D6 *6 | Frameshift deletion causing no enzyme function, defining poor metabolizer sta... | Pharmacogenomics | Established | |
| rs58440431 | CYP2D6 | Intronic CYP2D6 variant tagging East Asian *10-lineage suballeles; the C alle... | Pharmacogenomics | Strong | |
| rs71328650 | CYP2D6 | Intronic CYP2D6 haplotype tag variant (rs28371702 canonical form) associated ... | Pharmacogenomics | Emerging | |
| rs72549354 | CYP2D6 *20 | Frameshift insertion creating a null CYP2D6 allele; carriers cannot metaboliz... | Pharmacogenomics | Established |